Company profile

Akums Drugs & Pharmaceuticals Ltd, Haridwar, (India), is an internationally recognized WHO-GMP certified and one of the leading contract manufacturing and has rapidly emerged as the premier integrated pharmaceutical company in India. Its business focuses on the manufacture and marketing of pharmaceutical products and services to clients across the globe, portfolio includes a range of US-FDA norms producing HORMONAL preparations in Oral (Solid & Liquid) & Injectable forms, Skin Ointments & Cosmetic preparations, Oncology formulations and Contract Research and Manufacturing Services.



The company is one of the largest manufacturers and six state-of-the-art manufacturing facilities have huge per day capacity to produce formulations in practically all dosage forms, i.e. Tablets, Capsules, Soft Gels, Dry Syrups, Liquid Orals, Powder in Sachet, Dry & Liquid Injections, Pre-filled Syringes, Large Volume Parenterals (up to 100 ml) and Eye / Ear / Nasal Drops in Form Fill & Seal and Three Piece Packs. Exporters of Mint / Menthol derivatives and also manages state of the art research & development centers that offer the highest quality of Contract Research and Manufacturing Services. Over the years, Akums Drugs & Pharmaceuticals Ltd has established a global footprint in fulfilling the requirements of clients across the Globe.  


At Akums, we believe that if we take care of the present, we inspire a better future. It is this vision towards a disease-free world, a sustainable natural environment and a healthy global population, that supports our commitment to ensure the highest quality of products and services towards offering un-parallel care to our clients and to the larger community. The company currently supports a personnel base of more than 5500 employees in locations across India and has expanded its network of overseas offices. Set up a Research and Development Centre to Further strengthen its position as one of the leading exporters of pharmaceutical products.

  • Akums Plant -1
  • Akums Plant - II &III
  • Akums Plant-IV&V:
  • Akums MAXCURE

Commissioned in the year 2004 is the State-of-the-Art manufacturing facility producing Tablets, Capsules,
Soft-Gelatin Capsules & Dry Syrups with huge PER DAY manufacturing capacity in all
sections and has separate blocks for Beta Lactums, Non-Beta Lactums, Cephalosporin & Penicillin.

State-of-the-Art world class facilities established in the year 2007 are producing medicines in
the form of liquid orals and Jellies (in Plant II) and liquid & dry injections, large volume
parenterals, Pre-Filled Syringes and Eye/Ear/Nasal drops in FFS and Three piece pack (in Plant III).

world class Facility designed as per USA-FDA norms producing wide range of HORMONAL
preparations in Oral (Solid & Liquid) & Injectable forms and
fifth plant producing wide range of Skin Ointments & Cosmetic preparations were
commissioned in the year 2010.

the state-of-the-art-manufacturing facility was also set up in 2010 and manufacturing Ayurvedic,
Nutraceutical & Food supplements for top pharma companies of India.
Akums seventh state-of-the-art Manufacturing facility to produce world class Oncology formulations in Oral & Injectable forms is under construction and slated to commence production in the next financial year.


Unit /Production Plant

Akums units have been successfully audited and approved by the M.O.H. Departments of Belarus, Libya, Cuba, Ukraine and Nepal by the QA/QC personnel of foreign multi-national companies, namely; Ful-Ford (U.S.A.), Abbott (Chicago) Med-Interplast (Belarus), Alwatan (Libya), United Laboratories (Philippines), Kalbe International (Indonesia ), Ananta (Ukraine), Alter-ego (Ukraine), Coral Med (Russia ). The audit teams from Indian Multinational companies, namely; Sanofi-Aventis, Abbott, Wockhardt, Micro, Sun Pharma, Torrent, Lupin, Intas, Alembic, Emcure, Modi-Mundi, Zydus Cadila, Alkem, Blue Cross, FDC, Flamingo, Indoco, Win Medicare, Panacea, Nicholas Piramal, Glenmark, Ranbaxy, have approved all the units and getting their products manufactured at Akums either on Principal to Principal or Loan License basis for their domestic as well as export requirements.

View Site In  :